Transaction in Own Shares

Fidelity Emerging Markets Limited repurchased and cancelled 60,397 shares on 24 December 2025 at an average price of 1,043.97 GBp (range 1,040.00–1,044.00 GBp). Following the cancellation the issued share capital is 53,568,304, with 9,025,940 shares held in treasury and total voting rights of 44,542,365; the repurchase is modest (≈0.11% of issued capital) and likely intended to modestly boost per‑share metrics with limited market impact.

Analysis

Market structure: The cancelled buyback (60,397 shares at an avg £10.44 ≈ £0.63m) is a clear signaling action but economically tiny — ~0.11% of issued capital and ~0.14% of the free float — so direct liquidity/supply impact is marginal while signaling to holders that management sees the trust trading cheap to NAV. Short-term winners are existing long shareholders (potential discount compression) and active managers who can arbitrage the discount; passive EM ETF holders (EEM, VWO) are largely unaffected.

Risk assessment: Key tail risks are governance (9.03m shares in treasury = ~16.8% of issued and could be reissued) and funding choices (if buybacks are funded by selling concentrated or illiquid EM positions it could impair returns). Immediate risk window (days) is low volatility; short-term (weeks–months) the main risk is no follow‑through buyback causing the tiny announcement to be priced out; long-term (quarters) performance still driven by EM asset returns and currency moves (USD/EM FX) not this buyback.

Trade implications: The only sensible trade is a tactical, small-sized position to capture potential discount tightening: long the Fidelity Emerging Markets Limited trust (LSE-listed) sized 2–3% portfolio weight, paired 1:1 notional short of an EM ETF (EEM or VWO) to neutralize beta and isolate discount/NAV capture; target a 3–8% absolute return within 3 months if discount tightens by 100–300bp. Options: use a 3-month call spread on EEM (buy 1.5% delta, sell 0.5% delta) to express asymmetric upside exposure to an EM rally while financing part of cost.

Contrarian angles: The market may overreact positively to the optics — historical precedent shows closed‑end fund buybacks need sustained repurchases of 0.5–2% of issued over months to meaningfully move discounts. Treat current move as a trial balloon: if cumulative cancellations exceed 0.5% of issued within 3 months, upgrade to a larger position; if management starts reissuing treasury shares or no further buybacks occur, close the trade quickly (stop-loss -8%).

Key Decisions for Investors

• Establish a 2–3% portfolio long position in Fidelity Emerging Markets Limited (LSE-listed closed‑end trust) sized to risk buyback signaling; hedge EM beta by shorting an equivalent notional of iShares MSCI Emerging Markets ETF (EEM) or Vanguard FTSE Emerging Markets ETF (VWO), aim to capture 3–8% alpha within 3 months if discount narrows 100–300bp.
• If preferring an options route, buy a 3‑month call spread on EEM (long 10–15 delta, short 30 delta) sized to the notional of the trust exposure to express asymmetric upside to EM rally with limited premium; close if EM spot underperforms by 5% or implied vol rises >30% (sharp risk-off).
• Monitor three high‑conviction triggers over the next 90 days and act accordingly: (1) cumulative buybacks >0.5% of issued shares (increase long size to 4–6%), (2) management commentary committing to a sustained repurchase program (add), (3) any re‑issuance of treasury shares or suspension of buybacks (reduce/close position immediately).
• Avoid unhedged long exposure to passive EM ETFs or concentrated EM active funds; if you must hold, trim 5–10% of those positions and reallocate into the hedged trust trade because buyback signal disproportionately benefits closed‑end discount capture vs broad EM beta.